Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations
Enkhsaikhan Purevjav, Takuro Arimura, Sibylle Augustin, Anne-Cecile Huby, Ken Takagi, Shinichi Nunoda, Debra L Kearney, Michael D Taylor, Fumio Terasaki, Johan M Bos, Steve R Ommen, Hiroki Shibata, Megumi Takahashi, Manatsu Itoh-Satoh, William J McKenna, Ross T Murphy, Siegfried Labeit, Yoichi Yamanaka, Noboru Machida, Jeong-Euy Park Show all
Human Molecular Genetics | OXFORD UNIV PRESS | Published : 2012
Awarded by NIH
This work was supported in part by a Postdoctoral Fellowship and Beginning-Grant-in-Aid from the American Heart Association (E.P.), the Children's Cardiomyopathy Foundation (E.P., J.A.T.), the John Patrick Albright Foundation (J.A.T.) and NIH R01 HL53392, The Pediatric Cardiomyopathy Registry and R01 HL087000, The Pediatric Cardiomyopathy Specimen Repository (J.A.T.), Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology and grants from the Ministry of Health, Labour and Welfare, Japan; grants for Japan-France and Japan-Korea collaboration research from the Japan Society for the Promotion of Science; and grants from the Life Science Institute and Association Francaise contre les Myopathies, France (A.K., T.A.); the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program (M.J.A.).